Overview

REDPlanUP is a SaaS solution by Chryselys designed to accelerate clinical trial enrollment while ensuring health equity and compliance with FDA diversity requirements. It provides real-time insights into the racial and ethnic diversity of patients treated by investigators, helping pharmaceutical and life sciences organizations identify investigators with proven experience in diverse populations. The platform leverages patient-level claims and demographic data to visualize diversity indices, optimize recruitment strategies, and improve representation across clinical studies. All data handling follows HIPAA standards, enabling secure, compliant analytics for strategic trial planning.

Features and Capabilities

• Core Capabilities:
  • Diversity Analytics: Generates race and ethnicity diversity indices to assess patient population representation.
  • Investigator Profiling: Identifies clinicians and investigators with experience treating diverse patient cohorts.
  • Enrollment Optimization: Supports data-driven decisions to accelerate and stabilize trial recruitment timelines.
  • Compliance Support: Aligns recruitment planning with FDA diversity and inclusion requirements.
• Data Integration & Insights:
  • Robust Race Diversity Index: Analyzes patient mix across trial sites to guide recruitment focus.
  • Demographic Intelligence: Aggregates medical and pharmacy claims to build detailed patient population insights.
  • Investigator Experience Metrics: Uses historical trial involvement to identify high-performing investigators.
  • Payer Context Awareness: Incorporates payer and reimbursement context to support informed market access planning.
• Operational & Strategic Insights:
  • Trial Representation Strategy: Supports inclusion of underrepresented populations for more representative outcomes.
  • Cost & Resource Optimization: Helps sponsors allocate clinical resources more efficiently across sites.
  • Market Readiness Support: Data-driven insights accelerate drug development and go-to-market preparation.